These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34793610)

  • 1. Clearance of Lormetazepam, Midazolam, and Their Conjugated Metabolites by Continuous Venovenous Hemofiltration During Prolonged Sedation in Critically Ill Patients With COVID-19-Associated Acute Respiratory Distress Syndrome.
    Shudofsky KN; Janssen PKC; Foudraine N; le Noble JLML
    J Clin Pharmacol; 2022 Apr; 62(4):568-570. PubMed ID: 34793610
    [No Abstract]   [Full Text] [Related]  

  • 2. Population pharmacokinetics of lorazepam and midazolam and their metabolites in intensive care patients on continuous venovenous hemofiltration.
    Swart EL; de Jongh J; Zuideveld KP; Danhof M; Thijs LG; Strack van Schijndel RJ
    Am J Kidney Dis; 2005 Feb; 45(2):360-71. PubMed ID: 15685515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous infusion of lorazepam versus medazolam in patients in the intensive care unit: sedation with lorazepam is easier to manage and is more cost-effective.
    Swart EL; van Schijndel RJ; van Loenen AC; Thijs LG
    Crit Care Med; 1999 Aug; 27(8):1461-5. PubMed ID: 10470750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative population pharmacokinetics of lorazepam and midazolam during long-term continuous infusion in critically ill patients.
    Swart EL; Zuideveld KP; de Jongh J; Danhof M; Thijs LG; Strack van Schijndel RM
    Br J Clin Pharmacol; 2004 Feb; 57(2):135-45. PubMed ID: 14748812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population pharmacodynamic modelling of lorazepam- and midazolam-induced sedation upon long-term continuous infusion in critically ill patients.
    Swart EL; Zuideveld KP; de Jongh J; Danhof M; Thijs LG; Strack van Schijndel RM
    Eur J Clin Pharmacol; 2006 Mar; 62(3):185-94. PubMed ID: 16425056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High sedation needs of critically ill COVID-19 ARDS patients-A monocentric observational study.
    Flinspach AN; Booke H; Zacharowski K; Balaban Ü; Herrmann E; Adam EH
    PLoS One; 2021; 16(7):e0253778. PubMed ID: 34314422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered Pharmacokinetics in Prolonged Infusions of Sedatives and Analgesics Among Adult Critically Ill Patients: A Systematic Review.
    Tse AHW; Ling L; Lee A; Joynt GM
    Clin Ther; 2018 Sep; 40(9):1598-1615.e2. PubMed ID: 30173953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lorazepam and midazolam in the intensive care unit: a randomized, prospective, multicenter study of hemodynamics, oxygen transport, efficacy, and cost.
    Cernaianu AC; DelRossi AJ; Flum DR; Vassilidze TV; Ross SE; Cilley JH; Grosso MA; Boysen PG
    Crit Care Med; 1996 Feb; 24(2):222-8. PubMed ID: 8605792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind, randomized comparison of i.v. lorazepam versus midazolam for sedation of ICU patients via a pharmacologic model.
    Barr J; Zomorodi K; Bertaccini EJ; Shafer SL; Geller E
    Anesthesiology; 2001 Aug; 95(2):286-98. PubMed ID: 11506097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Midazolam Dose Optimization in Critically Ill Pediatric Patients With Acute Respiratory Failure: A Population Pharmacokinetic-Pharmacogenomic Study.
    Zuppa AF; Conrado DJ; Zane NR; Curley MAQ; Bradfield J; Hakonarson H; Gastonguay MS; Moorthy G; Prodell J; Gastonguay MR
    Crit Care Med; 2019 Apr; 47(4):e301-e309. PubMed ID: 30672747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Midazolam disposition in patients undergoing continuous venovenous hemodialysis.
    Bolon M; Bastien O; Flamens C; Paulus S; Boulieu R
    J Clin Pharmacol; 2001 Sep; 41(9):959-62. PubMed ID: 11549100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperinflammation Reduces Midazolam Metabolism in Critically Ill Adults with COVID-19.
    Smeets TJL; Valkenburg AJ; van der Jagt M; Koch BCP; Endeman H; Gommers DAMPJ; Sassen SDT; Hunfeld NGM
    Clin Pharmacokinet; 2022 Jul; 61(7):973-983. PubMed ID: 35397768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective multicentre randomised, double-blind, equivalence study comparing clonidine and midazolam as intravenous sedative agents in critically ill children: the SLEEPS (Safety profiLe, Efficacy and Equivalence in Paediatric intensive care Sedation) study.
    Wolf A; McKay A; Spowart C; Granville H; Boland A; Petrou S; Sutherland A; Gamble C
    Health Technol Assess; 2014 Dec; 18(71):1-212. PubMed ID: 26099138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoalbuminaemia and decreased midazolam clearance in terminally ill adult patients, an inflammatory effect?
    Franken LG; Masman AD; de Winter BCM; Baar FPM; Tibboel D; van Gelder T; Koch BCP; Mathot RAA
    Br J Clin Pharmacol; 2017 Aug; 83(8):1701-1712. PubMed ID: 28177137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Midazolam Infusion and Disease Severity Affect the Level of Sedation in Children: A Parametric Time-to-Event Analysis.
    Upadhyay PJ; Vet NJ; Goulooze SC; Krekels EHJ; de Wildt SN; Knibbe CAJ
    Pharm Res; 2021 Oct; 38(10):1711-1720. PubMed ID: 34664207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous infusions of lorazepam, midazolam, and propofol for sedation of the critically ill surgery trauma patient: a prospective, randomized comparison.
    McCollam JS; O'Neil MG; Norcross ED; Byrne TK; Reeves ST
    Crit Care Med; 1999 Nov; 27(11):2454-8. PubMed ID: 10579264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of midazolam in critically ill pediatric patients.
    Nahara MC; McMorrow J; Jones PR; Anglin D; Rosenberg R
    Eur J Drug Metab Pharmacokinet; 2000; 25(3-4):219-21. PubMed ID: 11420893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of lormetazepam and of flurazepam on sleep.
    Adam K; Oswald I
    Br J Clin Pharmacol; 1984 May; 17(5):531-8. PubMed ID: 6733001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacoeconomic modeling of lorazepam, midazolam, and propofol for continuous sedation in critically ill patients.
    MacLaren R; Sullivan PW
    Pharmacotherapy; 2005 Oct; 25(10):1319-28. PubMed ID: 16185175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged sedation of lorazepam due to absent UGT2B4/2B7 glucuronidation.
    Siller N; Egerer G; Weiss J; Mikus G
    Arch Toxicol; 2014 Jan; 88(1):179-80. PubMed ID: 24352535
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.